MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, recently announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 26,250 shares of its common stock to twenty-two newly-hired employees, with a grant date of August 1, 2023.
The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual’s employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.
The restricted stock units will vest in equal annual installments over four years, subject to each individual’s continued service with TELA Bio through the applicable vesting dates.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.